Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,252,000 | 4,453,780 | 0 | N/A | 0 |
| Depreciation Amortization | 708,000 | 604,240 | 0 | N/A | 0 |
| Other Working Capital | -513,000 | -977,740 | 0 | N/A | 0 |
| Other Operating Activity | -225,000 | -182,600 | 0 | 0 | 0 |
| Operating Cash Flow | $4,222,000 | $3,897,680 | $0 | $N/A | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -697,200 | 0 | N/A | 0 |
| Net Acquisitions | 0 | -26,560 | 0 | N/A | 0 |
| Other Investing Activity | -4,779,000 | -237,380 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,779,000 | $-961,140 | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | -2,083,300 | 0 | N/A | 0 |
| Other Financing Activity | 499,000 | 174,300 | 0 | 0 | 0 |
| Financing Cash Flow | $499,000 | $-1,909,000 | $0 | $N/A | $0 |
| Exchange Rate Effect | 0 | -84,660 | 0 | N/A | 0 |
| Net Cash Flow | $-58,000 | $1,027,460 | $0 | $N/A | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,222,000 | 3,897,680 | 0 | N/A | 0 |
| Free Cash Flow | 4,222,000 | 3,897,680 | 0 | 0 | 0 |